Tender detail
Intravenous human plasma-derived immunoglobulin medicine
Summary
Healthcare Public Procurement (HeCaPP) is procuring a pharmaceutical product containing immunoglobulins derived from human plasma for intravenous administration. The single lot covers supply to participating hospitals in Brussels and Woluwe-Saint-Lambert for a planned period of 48 months.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.